PHASE I DOSE ESCALATION STUDY OF SHR6508, A CALCIUM-SENSING RECEPTOR AGONIST, IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
Back
14 Apr 2024
5:45 p.m.
6:45 p.m.
WCN24-AB-786, Poster Board= SUN-209
Li Fan
Poster Presenter